Last updated 25/03/2025
Title
Expedient
Principal Investigator
Duration
Amount
Funder
| Role of the major histocompatibility complex as a prognostic and predictive biomarker in early and advanced stages of colorectal cancer |
| COLMENA24/01 |
| Rebeca Sanz Pamplona |
| 01/01/2025 - 31/12/2026 |
| The Beehive Foundation |
| Tumor neoantigens as a therapeutic target in pediatric solid tumors |
| ASPANOA23/01 |
| Sanz Pamplona, Rebeca |
| 11/01/2024 - 10/01/2026 |
| ASPANOA |
| Tumor neoantigens as a therapeutic target in pediatric solid tumors |
| ASPANOA23/01 |
| Sanz Pamplona, Rebeca |
| 11/01/2024 - 10/01/2026 |
| ASPANOA |
| Development of CAR-T immunotherapies with greater efficacy by modulating the anti-apoptotic machinery |
| ASPANOA24/01 |
| Sánchez Martínez, Diego |
| 31/12/2024 - 30/12/2026 |
| ASPANOA |
| Development of an organ-on-chip follicle model for in vitro maturation of human oocytes |
| MERCK23/01 |
| Bad Ladrero, Clara María |
| 12/05/2023 - 12/05/2026 |
| Merck Health Foundation |
| Use of extracellular vesicles from placental stem cells for the diagnosis and treatment of childhood tumors |
| ASPANOA22/02 |
| Martín Duque, María del Pilar |
| 26/05/2023 - 26/05/2025 |
| ASPANOA |
| Validation of mitochondrial inhibition as a new therapeutic strategy in advanced preclinical models of medulloblastoma |
| FCV_23_01 |
| Sancho Andrés, Patricia |
| 05/07/2023 - 04/07/2025 |
| FVC - Fernando Cuenca Villoro Foundation |
| Virtual biopsy: noninvasive diagnosis and monitoring of osteosarcomas using immunoguided imaging |
| BUESA2023/01 |
| Jiménez Schuhmacher, Alberto |
| 29/11/2023 - 30/11/2025 |
| GEIS BUESA |
| Targeting lipid signaling to improve treatment response in pancreatic cancer (LipidPanc) |
| AECCLAB2022 |
| Sancho Andrés, Patricia |
| 01/12/2022 - 30/11/2025 |
| AECC Foundation |
| Randomized controlled clinical trial comparing colonoscopy and fecal immunochemical occult blood screening for colorectal cancer. COLONPREV study |
| F21-154.0 |
| Lanas Arbeloa, Ángel |
| 01/11/2021 - 31/10/2026 |
| AECC Foundation |
Title
Expedient
Principal Investigator
Duration
Amount
Funder
| FEHH SCHOLARSHIP to support CAT certification |
| FEHH/22 |
| Delgado Beltrán, Pilar |
| 28/02/2022 - 28/02/2023 |
| FEHH - Spanish Foundation of Hematology and Hemotherapy |
| Evaluation of serum prolidase (PEPD) as a biomarker predicting fibrosis development in Crohn's disease. |
| GETECCU/2022/01 |
| Casas Deza, Diego |
| 01/10/2022 - 01/10/2024 |
| GETECCU - Spanish Working Group on Crohn's Disease and Ulcerative Colitis |
| Evaluation of obesity and metabolic syndrome as a risk factor for the development of inflammatory bowel disease. |
| GETECCU/2022/02 |
| Casas Deza, Diego |
| 01/10/2022 - 30/09/2024 |
| GETECCU - Spanish Working Group on Crohn's Disease and Ulcerative Colitis |
| Use of exosomes derived from CAR-T cells for the diagnosis and treatment of childhood tumors |
| AECCSEMILLA2022 |
| Martín Duque, María del Pilar |
| 01/12/2022 - 30/11/2024 |
| AECC Foundation |
| Preclinical study of the efficacy of CAR-NK cells against CD47 and GD2 and their preparation as a GMP product for the treatment of DIPG and neuroblastoma (nanoCAR-NK92) |
| ASPANOA22/01 |
| Jiménez Schuhmacher, Alberto |
| 26/12/2022 - 25/12/2024 |
| ASPANOA |
| Food, Physical Activity, Health and Sustainability (ALASS Program) |
| ALCAMPO/22 |
| By Miguel Etayo, Pilar |
| 15/09/2022 - 14/09/2024 |
| FOUNDATION AUCHAN |
| Childhood Obesity and adherence to the Mediterranean diet and lifestyle: MELI-POP (MEDITERRANEAN LIFESTYLE IN PEDIATRIC OBESITY PREVENTION) |
| 00400001 |
| Bueno Lozano, María Gloria |
| 11/02/2021 - 01/07/2023 |
| SEEP - Spanish Society of Pediatric Endocrinology |
| Promoting cardiovascular health: Early markers of kidney and cardiovascular damage in a cohort of workers |
| SCHOLARSHIPSEN17/01 |
| Íñigo Gil, Pablo |
| 08/01/2018 - 07/01/2023 |
| SENEFRO FOUNDATION |